GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Eone Diagnomics Genome Center Co Ltd (XKRX:245620) » Definitions » Capital Expenditure

Eone Diagnomics Genome Center Co (XKRX:245620) Capital Expenditure : ₩-6,082.57 Mil (TTM As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Eone Diagnomics Genome Center Co Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Eone Diagnomics Genome Center Co's cash flow for capital expenditures for the three months ended in Mar. 2024 was ₩0 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-6,082.57 Mil.

Eone Diagnomics Genome Center Co Capital Expenditure Historical Data

The historical data trend for Eone Diagnomics Genome Center Co's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eone Diagnomics Genome Center Co Capital Expenditure Chart

Eone Diagnomics Genome Center Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only -8,613.49 -5,747.42 -13,785.87 -39,409.02 -6,082.57

Eone Diagnomics Genome Center Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2,647.54 -1,929.66 -615.39 -889.97 -

Eone Diagnomics Genome Center Co Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-6,082.57 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eone Diagnomics Genome Center Co (XKRX:245620) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Eone Diagnomics Genome Center Co Ltd (XKRX:245620) » Definitions » Capital Expenditure
Comparable Companies
XKRX:086040 XKRX:253840 XKRX:122310 XKRX:363250 XKRX:221800 XKRX:950200 XKRX:031860 XKRX:347740 XKRX:153710 XKRX:229000 TMO DHR SHSE:603259 IDXX IQV A XSWX:LONN MTD ICLR ILMN
Traded in Other Exchanges
N/A
Address
4th Floor, 291 Harmony-ro, Yeonsu-Gu, Incheon, KOR, 22014
Website
http://www.edgc.com
Eeone Diagnomics Genome Center Co Ltd is engaged in developing and personalizing medicine based on Next Generation Sequencing technology and cutting edge genomics analysis. The company provides various personal genome sequencing and bioinformatics solutions to biomedical researchers, physicians and individuals seeking to understand the genetic influence of personal health and disease.

Eone Diagnomics Genome Center Co (XKRX:245620) Headlines

No Headlines